Thai Flu Strain Selected for WHO’s 2024 Vaccine


BANGKOK (NNT) – The World Health Organization (WHO) has incorporated a flu strain sequenced in Thailand into its trivalent influenza vaccine for the 2024 season in the Southern Hemisphere.

According to Acting Permanent Secretary for Public Health Yongyot Thammawut, the inclusion stems from a collaborative effort among vaccine regulatory agencies, manufacturers, and the WHO Global Influenza Surveillance and Response System. They convened in Geneva to determine the composition of the upcoming vaccine.

The Thai flu virus lineage was identified through extensive surveillance by the Department of Medical Sciences (DMS) within the Ministry of Public Health, in cooperation with the Department of Disease Control, various hospitals, and the Thailand office of the US Centers for Disease Control and Prevention.

This surveillance network, which reports its findings to the WHO weekly, helps guide international preventive measures against the flu. It is credited with effectively monitoring influenza strains and mutations circulating in Thailand.

In the current season, Thailand has observed a rise in influenza cases, with the influenza A (H3N2) strain being the most prevalent, accounting for two-thirds of all cases. Other strains, including influenza B and A (H1N1), are responsible for 19% and 14% of new infections, respectively.

The preceding is a press release from the Thai Government PR Department.

Goongnang Suksawat
Goong Nang is a News Translator who has worked professionally for multiple news organizations in Thailand for many years and has worked with The Pattaya News for more than four years. Specializes primarily in local news for Phuket, Pattaya, and also some national news, with emphasis on translation between Thai to English and working as an intermediary between reporters and English-speaking writers. Originally from Nakhon Si Thammarat, but lives in Phuket and Krabi except when commuting between the three.